Croma Pharma Launches AI-Driven Tech Venture to Revolutionize Aesthetic Medicine via Clinicore Platform

Commercial & Medical Affairs
Apr 24, 2026
Minimalist illustration of a syringe and facial silhouette in dark colors.

Croma Pharma has initiated a new joint venture aimed at enhancing its digital platform, Clinicore, which is tailored for aesthetic practices. This venture will focus on advancing the platform while maintaining seamless service for current users.

Clinicore is a SaaS solution that streamlines operations in aesthetic clinics by automating tasks such as patient management and scheduling. This allows healthcare providers to dedicate more time to patient care. The platform is set to incorporate advanced AI capabilities, transforming it into a smart assistant that enhances efficiency through features like automated treatment documentation and intelligent onboarding.

The collaboration with Medfile, a partner with extensive experience in medical software and AI development, will ensure that Clinicore remains at the forefront of medical technology. This partnership aligns with Croma’s strategy to integrate high-quality injectables with robust digital solutions, positioning the company as a comprehensive provider in the aesthetic market.

This initiative signifies Croma Pharma's commitment to investing in innovative technologies that equip healthcare professionals to adapt and thrive in an evolving landscape. By focusing on both product and digital infrastructure, Croma aims to strengthen its long-term relationships with clients while driving growth in the aesthetic medicine sector.

Read the original article: Business Wire